DN Debate: "The future of Swedish cancer care is in the hands of foreign countries"

Sweden's future cancer care is critically dependent on foreign-produced radioactive isotopes, creating a significant vulnerability in its healthcare system, according to a debate article in Dagens Nyheter.

The country relies on a limited number of aging nuclear reactors abroad to produce essential radioactive isotopes. These isotopes are crucial for modern diagnostics, cancer treatment, radiation therapy, and the sterilization of medical instruments. They must be delivered to hospitals within hours of production.

This reliance has already led to serious consequences. In the fall of 2024, several university hospitals were forced to postpone examinations for cancer and heart patients due to a disruption in a reactor in Petten, Netherlands, which affected the supply of technetium-based radiopharmaceuticals across Europe. The global supply of medical isotopes rests on reactors built in the 1950s and 60s, many of which are nearing the end of their operational life without clear replacements.

The article highlights that advanced treatments like theranostics, which combine diagnostics and treatment using radioactive drugs, are the future of cancer care. These methods depend on isotopes like lutetium-177 and actinium-225, which can only be produced in a restricted number of reactors. With millions of radioisotope-based procedures performed annually in the EU and a projected annual growth of 10-15 percent, production capacity is not keeping pace with demand.

In an era of increasing geopolitical uncertainty, the authors argue it is unreasonable for critical medical functions to be entirely dependent on imported isotopes without any domestic backup. They contend that nations controlling isotope production will lead research and attract talent. Without domestic capacity, Sweden risks falling behind in next-generation cancer care. The authors stress that this issue is as vital as pharmaceutical preparedness, vaccine production, or hospital backup power, emphasizing the need for healthcare resilience.